Tyra Biosciences (TYRA)
(Delayed Data from NSDQ)
$16.11 USD
-1.04 (-6.06%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $16.09 -0.02 (-0.12%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/18/25 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.41 |
Last EPS Surprise | -2.50% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.53 |
Next Year | -1.90 |
EPS (TTM) | -1.61 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.43 | -1.53 | -1.90 |
# of Estimates | 5 | 3 | 7 | 7 |
Most Recent Consensus | -0.39 | -0.36 | -1.42 | -1.58 |
High Estimate | -0.36 | -0.38 | -1.41 | -1.58 |
Low Estimate | -0.48 | -0.46 | -1.61 | -2.25 |
Year ago EPS | -0.53 | -0.35 | -1.62 | -1.53 |
Year over Year Growth Est. | 18.87% | -22.86% | 5.56% | -24.37% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.43 | -1.53 | -1.90 |
7 Days Ago | -0.43 | -0.43 | -1.53 | -1.90 |
30 Days Ago | -0.43 | -0.43 | -1.53 | -1.90 |
60 Days Ago | -0.43 | -0.43 | -1.53 | -1.90 |
90 Days Ago | -0.42 | -0.42 | -1.52 | -1.89 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.43 | -0.43 | -1.54 | -1.93 |
Zacks Consensus Estimate | -0.43 | -0.43 | -1.53 | -1.90 |
Earnings ESP | 0.00% | 0.00% | -0.65% | -1.42% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.41 | -0.32 | -0.35 | -0.53 | NA |
Estimate | -0.40 | -0.41 | -0.46 | -0.48 | NA |
Difference | -0.01 | 0.09 | 0.11 | -0.05 | 0.04 |
Surprise | -2.50% | 21.95% | 23.91% | -10.42% | 8.24% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more